ダウンロード数: 192
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
30_1691.pdf | 266.98 kB | Adobe PDF | 見る/開く |
タイトル: | Enzyme immunoassay法による前立腺性酸性フォスファターゼの検討 |
その他のタイトル: | Prostatic acid phosphatase by enzymeimmunoassay |
著者: | 桝鏡, 年清 安藤, 研 島崎, 淳 |
著者名の別形: | MASUKAGAMI, Toshikiyo ANDO, Ken SHIMAZAKI, Jun |
キーワード: | Prostatic acid phosphatase Enzymeimmunoassay Prostatic cancer |
発行日: | Nov-1984 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 30 |
号: | 11 |
開始ページ: | 1691 |
終了ページ: | 1695 |
抄録: | We measured prostatic acid phosphatase levels by enzymeimmunoassay (PAP-EIA). Intraassay reproducibility of PAP-EIA was markedly good. In thirty normal males, PAP-EIA levels ranged from 0.24 ng/ml to 3.3 ng/ml, mean and S.D. being 0.94 ng/ml, 0.50 ng/ml, respectively. We made the upper limit of PAP-EIA for the normal range, 1.94 ng/ml (Mean + 2 S.D.). O 40 patients with untreated prostatic cancer, 34 patients (85%) gave positive results (1/3 33% of stage A, 3/4 75% B, 10/11 90% C, 20/22 90% D). One out of 12 patients with BPH, and one out of 11 with prostatitis gave positive results. The false positive rate was 9%. PAP levels of 324 samples from 111 patients with prostatic cancer were measured by EIA and radioimmunoassay (RIA). A significant correlation was noted between EIA and RIA (r = 0.997 p less than 0.001). |
URI: | http://hdl.handle.net/2433/118318 |
PubMed ID: | 6084950 |
出現コレクション: | Vol.30 No.11 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。